Address
CMEA Capital
One Embarcadero Center
Suite 3250
San Francisco, CA 94111
United States
Phone
Website
Recent investment activity
Tags
KANDO id: 29362
Corporate information
Founders
Also known as
CMEA Ventures
Chemical and Materials Enterprise Associates
Registration country
Funding rounds
Top investment portfolio themes
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 56Company | Profile | Country | Date Sort descending | Funding | ||
---|---|---|---|---|---|---|
Entropic Communications Inc | Fabless semiconductor company. | Series C Follow-on investment | ||||
Strix Systems Inc | Series B | |||||
Codexis Inc | Engages in the production of custom industrial enzymes for use in the manufacture of biofuels, chemicals, and pharmaceutical ingredients. | Series D | ||||
Intermolecular Inc | Series C Initial investment | |||||
Visiogen Inc | A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. | N/A Initial investment | ||||
AirTight Networks Inc | Provider of comprehensive Wi-Fi intrusion detection, wireless LAN planning, monitoring, and security solutions. | Series C | ||||
Streamlite Inc | Technology-enabled shipping company. | Series B | ||||
Relypsa Inc | Leads the discovery and development of new non-absorbed polymeric drugs | Series A | ||||
InSound Medical Inc | Medical device company focused on the development and sale of next generation hearing aid solutions. | Series E | ||||
Luminus Devices Inc | Development and manufacturing of high performance solid state light sources for a variety of illumination applications | Series E | ||||
SpikeSource Inc | Open source focused, software certification company. | Series C | ||||
Blekko Inc | Provide a differentiated editorial voice in search | Series B | ||||
Auspex Pharmaceuticals Inc | Series B | |||||
Tetraphase Pharmaceuticals Inc | A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. | Series A | ||||
VasoNova Inc | Leader in algorithm-based vascular navigation and measurement technology. | Series B | ||||
Symwave | Developer and marketer of high-performance analog/mixed-signal integrated circuits and system solutions. | Series C | ||||
Solyndra LLC | Maker of photovoltaic systems for the commercial rooftop market | Series E Exited | ||||
Intermolecular Inc | Series D Initial investment | |||||
Visiogen Inc | A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. | Series D Initial investment | ||||
Blekko Inc | Provide a differentiated editorial voice in search | Series C | ||||
Intellikine | Series B | |||||
Schooner Information Technology Inc | Enterprise storage software company. | Series B | ||||
Solaria Corp | Low concentration PV modules | Debt | ||||
Danotek Motion Technologies | A Canton, Michigan - based developer of generators and components to supply wind energy to the power grid | Series B | ||||
Tetraphase Pharmaceuticals Inc | A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. | Series C |